Works matching DE "ALISKIREN"

Results: 217

Intestinal OATP1A2 inhibition as a potential mechanism for the effect of grapefruit juice on aliskiren pharmacokinetics in healthy subjects.

Published in:

European Journal of Clinical Pharmacology, 2012, v. 68, n. 5, p. 697, doi. 10.1007/s00228-011-1167-4

By:

Rebello, Sam;
Zhao, Sally;
Hariry, Sam;
Dahlke, Marion;
Alexander, Natalya;
Vapurcuyan, Arpine;
Hanna, Imad;
Jarugula, Venkateswar

Publication type:

Article

Renin Inhibition with Aliskiren: A Decade of Clinical Experience.

Published in:

Journal of Clinical Medicine, 2017, v. 6, n. 6, p. 61, doi. 10.3390/jcm6060061

By:

Pantzaris, Nikolaos-Dimitrios;
Karanikolas, Evangelos;
Tsiotsios, Konstantinos;
Velissaris, Dimitrios

Publication type:

Article

DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-HPLC METHOD FOR DETERMINATION OF ALISKIREN IN BULK AND PHARMACEUTICAL DOSAGE FORMS.

Published in:

International Journal of Chemical & Pharmaceutical Analysis, 2015, v. 2, n. 4, p. 1

By:

Gupta, Krishna R.;
Kale, Kiran N.

Publication type:

Article

Angioedema Among Hypertensive Patients Treated with Aliskiren or Other Antihypertensive Medications in the United States.

Published in:

American Journal of Cardiovascular Drugs, 2017, v. 17, n. 6, p. 465, doi. 10.1007/s40256-017-0242-3

By:

Schlienger, Raymond;
Korn, Jonathan;
Wehler, Elizabeth;
Lopez Leon, Sandra;
Yeaw, Jason

Publication type:

Article

Incidence of Ischemic Colitis in Treated, Commercially Insured Hypertensive Adults: A Cohort Study of US Health Claims Data.

Published in:

American Journal of Cardiovascular Drugs, 2015, v. 15, n. 2, p. 135, doi. 10.1007/s40256-014-0101-4

By:

Hines, Dionne;
McGuiness, Catherine;
Schlienger, Raymond;
Makin, Charles

Publication type:

Article

Antihypertensive Drugs, Hypotension, and Ischemic Colitis.

Published in:

American Journal of Cardiovascular Drugs, 2015, v. 15, n. 2, p. 77, doi. 10.1007/s40256-015-0112-9

By:

Blin, Patrick

Publication type:

Article

Epidemiology and Management of Hypertension in the Hispanic Population.

Published in:

American Journal of Cardiovascular Drugs, 2012, v. 12, n. 3, p. 165, doi. 10.2165/11631520-000000000-00000

By:

Guzman, Nicolas J.

Publication type:

Article

Aliskiren as Add-On Therapy in the Treatment of Hypertensive Diabetic Patients Inadequately Controlled with Valsartan/HCT Combination: A Placebo-Controlled Study.

Published in:

American Journal of Cardiovascular Drugs, 2011, v. 11, n. 5, p. 327, doi. 10.2165/11591970-000000000-00000

By:

Drummond, W.;
Sirenko, Y. M.;
Ramos, E.;
Baek, I.;
Keefe, D. L.

Publication type:

Article

The Role of Direct Renin Inhibition in Clinical Practice: Focus on Combination Therapy.

Published in:

American Journal of Cardiovascular Drugs, 2011, v. 11, n. 5, p. 303, doi. 10.2165/11594140-000000000-00000

By:

Rashid, Haroon-Ur;
Mende, Christian

Publication type:

Article

Aliskiren in the Management of Hypertension.

Published in:

American Journal of Cardiovascular Drugs, 2010, v. 10, n. 6, p. 349, doi. 10.2165/11584980-000000000-00000

By:

Barrios, Vivencio;
Escobar, Carlos

Publication type:

Article

Compliance, Persistence, Healthcare Resource Use, and Treatment Costs Associated with Aliskiren plus ARB versus ACE Inhibitor plus ARB Combination Therapy.

Published in:

American Journal of Cardiovascular Drugs, 2011, v. 11, n. 1, p. 21, doi. 10.2165/11586570-000000000-00000

By:

Joanne Chang;
Weiyi Yang;
Kahler, Kristijan H.;
Fellers, Thomas;
Orloff, John;
Bensimon, Arielle G.;
Yu, Andrew P.;
Fan, Chun-Po Steve;
Wu, Eric Q.

Publication type:

Article

Risk of Hospitalization Associated with Cardiovascular Medications in the Elderly Italian Population: A Nationwide Multicenter Study in Emergency Departments.

Published in:

Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.611102

By:

Crescioli, Giada;
Bettiol, Alessandra;
Bonaiuti, Roberto;
Tuccori, Marco;
Rossi, Marco;
Capuano, Annalisa;
Pagani, Silvia;
Spada, Giulia;
Venegoni, Mauro;
Vighi, Giuseppe Danilo;
Mannaioni, Guido;
Vannacci, Alfredo;
Lombardi, Niccolò

Publication type:

Article

Geographical Variation in Medication Prescriptions: A Multiregional Drug-Utilization Study.

Published in:

Frontiers in Pharmacology, 2020, v. 11, p. 1, doi. 10.3389/fphar.2020.00418

By:

Russo, Veronica;
Orlando, Valentina;
Monetti, Valeria Marina;
Galimberti, Federica;
Casula, Manuela;
Olmastroni, Elena;
Tragni, Elena;
Menditto, Enrica;
Catapanoa, Alberico L.;
Corrao, Giovanni;
Mucherino, Sara;
Scotti, Lorenza;
Zambon, Antonella;
Gambera, Marco;
Piccinelli, Rossana;
Sonzogni, Samanta;
Valsecchi, Valter;
Scopinaro, Eugenio;
Raineri, Sandro;
Speziali, Alessia

Publication type:

Article

Aliskiren and the dual complement inhibition concept.

Published in:

Clinical Kidney Journal, 2020, v. 13, n. 1, p. 35, doi. 10.1093/ckj/sfz142

By:

Perez-Gomez, Maria Vanessa;
Ortiz, Alberto

Publication type:

Article

Aliskiren as an adjunct therapy for atypical hemolytic uremic syndrome.

Published in:

Clinical Kidney Journal, 2020, v. 13, n. 1, p. 39, doi. 10.1093/ckj/sfz146

By:

Plasse, Richard A;
Nee, Robert;
Olson, Stephen W

Publication type:

Article

TAK-272 (imarikiren), a novel renin inhibitor, improves cardiac remodeling and mortality in a murine heart failure model.

Published in:

PLoS ONE, 2018, v. 13, n. 8, p. 1, doi. 10.1371/journal.pone.0202176

By:

Hara, Tomoya;
Nishimura, Satoshi;
Yamamoto, Toshihiro;
Kajimoto, Yumiko;
Kusumoto, Keiji;
Kanagawa, Ray;
Ikeda, Shota;
Nishimoto, Tomoyuki

Publication type:

Article

Correction: Treatment combining aliskiren with paricalcitol is effective against progressive renal tubulointerstitial fibrosis via dual blockade of intrarenal renin.

Published in:

2018

By:

Chung, Sungjin;
Kim, Soojeong;
Kim, Minyoung;
Koh, Eun Sil;
Shin, Seok Joon;
Park, Cheol Whee;
Chang, Yoon Sik;
Kim, Ho-Shik

Publication type:

Correction Notice

A Stereoselective Catalytic Nitroaldol Reaction as the Key Step in a Strategy for the Synthesis of the Renin Inhibitor Aliskiren.

Published in:

European Journal of Organic Chemistry, 2015, v. 2015, n. 11, p. 2531, doi. 10.1002/ejoc.201403659

By:

Rossi, Sergio;
Benaglia, Maurizio;
Porta, Riccardo;
Cotarca, Livius;
Maragni, Paolo;
Verzini, Massimo

Publication type:

Article

Laboratory medicine in arterial hypertension.

Published in:

Biochemia Medica, 2023, v. 33, n. 1, p. 1, doi. 10.11613/BM.2023.010501

By:

Aralica, Merica;
Šupak-Smolčić, Vesna;
Honović, Lorena;
Franin, Lucija;
Šonjić, Pavica;
Šimac, Maja;
Horvat, Mihovil;
Poropat, Nina

Publication type:

Article

2012 - Aliskiren increased adverse events in patients with diabetes and kidney disease who were receiving ACE inhibitors or ARBs.

Published in:

ACP Journal Club, 2013, v. 158, n. 6, p. 1, doi. 10.7326/0003-4819-158-6-201303190-02007

By:

de Leeuw, Peter W.

Publication type:

Article

2012 - Review: Aliskiren plus ACEIs or ARBs increases hyperkalemia more than aliskiren, ACEIs, or ARBs alone.

Published in:

ACP Journal Club, 2012, v. 156, n. 6, p. 1, doi. 10.7326/0003-4819-156-12-201206190-02009

By:

Moist, Louise

Publication type:

Article

Aliskiren, ALTITUDE, and the implications for ATMOSPHERE.

Published in:

European Journal of Heart Failure, 2012, v. 14, n. 4, p. 341, doi. 10.1093/eurjhf/hfs033

By:

McMurray, John J.V.;
Abraham, William T.;
Dickstein, Kenneth;
Køber, Lars;
Massie, Barry M.;
Krum, Henry

Publication type:

Article

Left ventricular systolic and diastolic function, remodelling, and clinical outcomes among patients with diabetes following myocardial infarction and the influence of direct renin inhibition with aliskiren.

Published in:

European Journal of Heart Failure, 2012, v. 14, n. 2, p. 185, doi. 10.1093/eurjhf/hfr125

By:

Shah, Amil M.;
Shin, Sung Hee;
Takeuchi, Madoka;
Skali, Hicham;
Desai, Akshay S.;
Køber, Lars;
Maggioni, Aldo P.;
Rouleau, Jean L.;
Kelly, Roxzana Y.;
Hester, Allen;
Keefe, Deborah;
McMurray, John J. V.;
Pfeffer, Marc A.;
Solomon, Scott D.

Publication type:

Article

Current studies of diabetic cardiomyopathy and the advancement of our knowledge: time to learn from history, guidelines, … and other disciplines?

Published in:

European Journal of Heart Failure, 2012, v. 14, n. 2, p. 115, doi. 10.1093/eurjhf/hfr180

By:

Diamant, Michaela

Publication type:

Article

Formal Total Synthesis of Aliskiren.

Published in:

Chemistry - A European Journal, 2015, v. 21, n. 19, p. 7292, doi. 10.1002/chem.201406523

By:

Peters, Byron K.;
Liu, Jianguo;
Margarita, Cristiana;
Andersson, Pher G.

Publication type:

Article

Effect of combination of renin inhibitor and Mas-receptor agonist in DOCA-salt-induced hypertension in rats.

Published in:

Molecular & Cellular Biochemistry, 2013, v. 373, n. 1/2, p. 189, doi. 10.1007/s11010-012-1489-2

By:

Singh, Yogendra;
Singh, Kulwinder;
Sharma, P.

Publication type:

Article

Renin–Angiotensin System Blocking Drugs.

Published in:

Journal of Cardiovascular Pharmacology & Therapeutics, 2014, v. 19, n. 1, p. 14, doi. 10.1177/1074248413501018

By:

Robles, Nicolás Roberto;
Cerezo, Isis;
Hernandez-Gallego, Roman

Publication type:

Article

Aliskiren – a promising strategy for ovarian ischemia/reperfusion injury protection in rats via RAAS.

Published in:

Gynecological Endocrinology, 2016, v. 32, n. 8, p. 675, doi. 10.3109/09513590.2016.1153055

By:

Bayir, Yasin;
Cadirci, Elif;
Polat, Beyzagul;
Kilic Baygutalp, Nurcan;
Albayrak, Abdulmecit;
Karakus, Emre;
Un, Harun;
Keles, Mevlut Sait;
Kocak Ozgeris, Fatma Betul;
Toktay, Erdem;
Karaca, Mehmet;
Halici, Zekai

Publication type:

Article

THEORETICAL STUDIES OF PLASMA-RENIN ACTIVITY AFTER A NIFEDIPINE TREATMENT.

Published in:

Journal of Chemical Technology & Metallurgy, 2020, v. 55, n. 6, p. 2020

By:

Yankov, Kaloyan B.

Publication type:

Article

Antidepressant-like Effects of Renin Inhibitor Aliskiren in an Inflammatory Mouse Model of Depression.

Published in:

Brain Sciences (2076-3425), 2022, v. 12, n. 5, p. 655, doi. 10.3390/brainsci12050655

By:

Alzarea, Sami I.;
Alhassan, Hassan H.;
Alzarea, Abdulaziz I.;
Al-Oanzi, Ziad H.;
Afzal, Muhammad

Publication type:

Article

The potential for improved outcomes in the prevention and therapy of diabetic kidney disease through 'stacking' of drugs from different classes.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2046, doi. 10.1111/dom.15559

By:

Bell, David S. H.;
Jerkins, Terri

Publication type:

Article

Inhibition of IL-1β by Aliskiren Improved Renal AQP2 Expression and Urinary Concentration Defect in Ureteral Obstruction and Release.

Published in:

Frontiers in Physiology, 2019, p. 1, doi. 10.3389/fphys.2019.01157

By:

Hu, Shan;
Xie, Haixia;
Luo, Renfei;
Feng, Pinning;
Liu, Qiaojuan;
Han, Mengke;
Kong, Yonglun;
Zou, Xuenong;
Wang, Weidong;
Li, Chunling

Publication type:

Article

Inhibition of IL-1β by Aliskiren Improved Renal AQP2 Expression and Urinary Concentration Defect in Ureteral Obstruction and Release.

Published in:

Frontiers in Physiology, 2019, p. 1, doi. 10.3389/fphys.2019.01157

By:

Hu, Shan;
Xie, Haixia;
Luo, Renfei;
Feng, Pinning;
Liu, Qiaojuan;
Han, Mengke;
Kong, Yonglun;
Zou, Xuenong;
Wang, Weidong;
Li, Chunling

Publication type:

Article

Central Application of Aliskiren, a Renin Inhibitor, Improves Outcome After Experimental Stroke Independent of Its Blood Pressure Lowering Effect.

Published in:

Frontiers in Neurology, 2019, p. 1, doi. 10.3389/fneur.2019.00942

By:

Panahpour, Hamdollah;
Terpolilli, Nicole A.;
Schaffert, David;
Culmsee, Carsten;
Plesnila, Nikolaus

Publication type:

Article

Comparative evaluation of aliskiren, ramipril, and losartan on psychomotor performance in healthy volunteers: A preliminary report.

Published in:

Perspectives in Clinical Research, 2014, v. 5, n. 4, p. 190, doi. 10.4103/2229-3485.140564

By:

Arora, Ekta;
Khajuria, Vijay;
Tandon, Vishal R.;
Sharma, Atul;
Choudhary, Naiyma

Publication type:

Article

A Validated Stability Indicating RP-HPLC Method Development and Validation for Simultaneous Estimation of Aliskiren Hemifumarate and Amlodipine Besylate in Pharmaceutical Dosage Form.

Published in:

Chromatography Research International, 2014, p. 1, doi. 10.1155/2014/628319

By:

Runja, Chinnalalaiah;
Ravikumar, P.;
Avanapu, Srinivasa Rao

Publication type:

Article

Aliskiren effect on non-alcoholic steatohepatitis in metabolic syndrome.

Published in:

Diabetology & Metabolic Syndrome, 2017, v. 9, p. 1, doi. 10.1186/s13098-017-0282-5

By:

Ramalho, F. N.;
Sanches, S. C.;
Foss, M. C.;
Augusto, M. J.;
Silva, D. M.;
Oliveira, A. M.;
Ramalho, L. N.

Publication type:

Article

Direct Renin Inhibition with Aliskiren Improves Ischemia-Induced Neovasculogenesis in Diabetic Animals via the SDF-1 Related Mechanism.

Published in:

PLoS ONE, 2015, v. 10, n. 8, p. 1, doi. 10.1371/journal.pone.0136627

By:

Chang, Ting-Ting;
Wu, Tao-Cheng;
Huang, Po-Hsun;
Lin, Chih-Pei;
Chen, Jia-Shiong;
Lin, Liang-Yu;
Lin, Shing-Jong;
Chen, Jaw-Wen

Publication type:

Article

Aliskiren Attenuates Steatohepatitis and Increases Turnover of Hepatic Fat in Mice Fed with a Methionine and Choline Deficient Diet.

Published in:

PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0077817

By:

Lee, Kuei-Chuan;
Chan, Che-Chang;
Yang, Ying-Ying;
Hsieh, Yun-Cheng;
Huang, Yi-Hsiang;
Lin, Han-Chieh

Publication type:

Article

Aliskiren and Amlodipine in the Management of Essential Hypertension: Meta-Analysis of Randomized Controlled Trials.

Published in:

PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0070111

By:

Liu, Yukai;
Chen, Ken;
Kou, Xun;
Han, Yu;
Zhou, Lin;
Zeng, Chunyu

Publication type:

Article

The Safety and Short-Term Efficacy of Aliskiren in the Treatment of Immunoglobulin A Nephropathy – A Randomized Cross-Over Study

Published in:

PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0062736

By:

Szeto, Cheuk-Chun;
Kwan, Bonnie Ching-Ha;
Chow, Kai-Ming;
Leung, Chi-Bon;
Li, Philip Kam-Tao

Publication type:

Article

Aliskiren Prevents the Toxic Effects of Peritoneal Dialysis Fluids during Chronic Dialysis in Rats.

Published in:

PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0036268

By:

Pérez-Martínez, Juan;
Pérez-Martínez, Francisco C.;
Carrión, Blanca;
Masiá, Jesú s;
Ortega, Agustín;
Simarro, Esther;
Nam-Cha, Syong H.;
Ceña, Valentín

Publication type:

Article

Product Update.

Published in:

Canadian Pharmacists Journal, 2012, v. 145, n. 4, p. 161, doi. 10.3821/145.4.cpj161

By:

Bhalla, Alka

Publication type:

Article

Effects of aliskiren- and ramipril-based treatment on central aortic blood pressure in elderly with systolic hypertension: a substudy of AGELESS.

Published in:

Vascular Health & Risk Management, 2014, v. 10, p. 389, doi. 10.2147/VHRM.S63725

By:

Baschiera, Fabio;
Chang, William;
Brunel, Patrick

Publication type:

Article

SÍNDROME DE BARTTER.

Published in:

Acta Médica Portuguesa, 2011, v. 24, n. S3, p. 671

By:

MENDONÇA, Marta;
PINHEIRO, Adriana;
CASTRO, Isabel

Publication type:

Article

New drugs and dosage forms.

Published in:: American Journal of Health-System Pharmacy, 2018, v. 75, n. 1, p. e2, doi. 10.2146/news180001
Publication type:: Article

Combination of Chymostatin and Aliskiren attenuates ER stress induced by lipid overload in kidney tubular cells.

Published in:

Lipids in Health & Disease, 2018, v. 17, n. 1, p. N.PAG, doi. 10.1186/s12944-018-0818-1

By:

Qiu, Miaojuan;
Li, Suchun;
Jin, Lizi;
Feng, Pinning;
Kong, Yonglun;
Zhao, Xiaoduo;
Lin, Yu;
Xu, Yunyun;
Li, Chunling;
Wang, Weidong

Publication type:

Article

Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 Trial.

Published in:: Current Medical Literature: Cardiology, 2010, v. 29, n. 4, p. 116
Publication type:: Article

Attenuation of atrial remodeling by aliskiren via affecting oxidative stress, inflammation and PI3K/Akt signaling pathway.

Published in:

Cardiovascular Drugs & Therapy, 2021, v. 35, n. 3, p. 587, doi. 10.1007/s10557-020-07002-z

By:

Zhao, Zhiqiang;
Li, Ruiling;
Wang, Xinghua;
Li, Jian;
Yuan, Meng;
Liu, Enzhao;
Liu, Tong;
Li, Guangping

Publication type:

Article

Protective Effects of Aliskiren on Atrial Ionic Remodeling in a Canine Model of Rapid Atrial Pacing.

Published in:

Cardiovascular Drugs & Therapy, 2014, v. 28, n. 2, p. 137, doi. 10.1007/s10557-014-6509-x

By:

Zhao, Zhiqiang;
Wang, Xinghua;
Li, Jian;
Yang, Wansong;
Cheng, Lijun;
Chen, Yan;
Liu, Tong;
Liu, Enzhao;
Chen, Kangyin;
Li, Guangping

Publication type:

Article